Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Genome Medicine|January 8, 2016
A multi-factorial analysis of response to warfarin in a UK prospective cohortStephane Bourgeois, Andrea Jorgensen, Eunice J Zhang, et al.Plos One|January 30, 2020
A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South AfricaJerome Roy Semakula, Johannes P Mouton, Andrea Jorgensen, et al.The American Journal of Clinical Nutrition|February 1, 2022
Vitamin D, vitamin D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patientsSreedhar Subramanian, Jonathan M Rhodes, Joseph M Taylor, et al.Health Technology Assessment (Winchester, England)|July 24, 2014
Folate Augmentation of Treatment--Evaluation for Depression (FolATED): randomised trial and economic evaluationEmma Bedson, Diana Bell, Daniel Carr, et al.The Journal of Clinical Investigation|May 16, 2017
Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsyLauren Elizabeth Walker, Federica Frigerio, Teresa Ravizza, et al.Blood|March 6, 2010
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groupsNita A Limdi, Mia Wadelius, Larisa Cavallari, et al.Rheumatology (Oxford, England)|December 11, 2021
Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupusEve M D Smith, Kukatharmini Tharmaratnam, Eslam Al-Abadi, et al.Journal of Personalized Medicine|August 27, 2021
Identification of ROBO2 as a Potential Locus Associated with Inhaled Corticosteroid Response in Childhood AsthmaNatalia Hernandez-Pacheco, Mario Gorenjak, Jiang Li, et al.Human Molecular Genetics|August 22, 2013
A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsyDoug Speed, Clive Hoggart, Slave Petrovski, et al.Pageof 3